{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T20:25:35Z","timestamp":1748550335471},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T00:00:00Z","timestamp":1365033600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0060387","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T22:27:16Z","timestamp":1365114436000},"page":"e60387","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Immune Biomarker Differences and Changes Comparing HCV Mono-Infected, HIV\/HCV Co-Infected, and HCV Spontaneously Cleared Patients"],"prefix":"10.1371","volume":"8","author":[{"given":"Lauren E.","family":"Kushner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron M.","family":"Wendelboe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura C.","family":"Lazzeroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aarthi","family":"Chary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Winters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu","family":"Osinusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam","family":"Kottilil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Polis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Holodniy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,4,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cyto.2007.05.013","article-title":"Chemokines in hepatitis C virus infection: Pathogenesis, prognosis and therapeutics","volume":"39","author":"O Wald","year":"2007","journal-title":"Cytokine"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2893.2008.00974.x","article-title":"Fas\/FasL system, IL-1\u03b2 expression and apoptosis in chronic HBV and HCV liver disease","volume":"15","author":"M Bortolami","year":"2008","journal-title":"Journal of Viral Hepatitis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.3748\/wjg.14.7149","article-title":"Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection","volume":"14","author":"J Larrubia","year":"2008","journal-title":"World Journal of Gastroenterology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/COH.0b013e32834bbc71","article-title":"HIV and hepatitis C coinfection: pathogenesis and microbial translocation","volume":"6","author":"E Page","year":"2011","journal-title":"Current opinion in HIV and AIDS"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/hep.22763","article-title":"Chemokines in the immunopathogenesis of hepatitis C infection","volume":"49","author":"M Heydtmann","year":"2009","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/QAD.0b013e3282f3553b","article-title":"Intrahepatic mRNA expression in hepatitis C virus and HIV\/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART","volume":"22","author":"T Kuntzen","year":"2008","journal-title":"AIDS"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/00002030-199907300-00007","article-title":"Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV\/hepatitis C virus-coinfected patients","volume":"13","author":"RP Woitas","year":"1999","journal-title":"AIDS"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/01.aids.0000168970.80551.3d","article-title":"Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection","volume":"19","author":"C Graham","year":"2005","journal-title":"AIDS"},{"key":"ref9","first-page":"15","article-title":"Pathogenesis of liver damage in HCV-HIV patients","volume":"10","author":"R Bruno","year":"2008","journal-title":"AIDS reviews"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.2174\/092986708786848668","article-title":"Metabolic-Inflammatory Changes, and Accelerated Atherosclerosis in HIV Patients: Rationale for Preventative Measures","volume":"15","author":"F De Lorenzo","year":"2008","journal-title":"Current Medicinal Chemistry"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/QAD.0b013e32832995fa","article-title":"HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial","volume":"23","author":"A Calmy","year":"2009","journal-title":"AIDS"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/COH.0b013e3282fb7be0","article-title":"Pathogenesis of cardiovascular disease in HIV infection","volume":"3","author":"A Carr","year":"2008","journal-title":"Current Opinion in HIV & AIDS"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ahj.2005.07.030","article-title":"Cardiovascular disease in HIV infection","volume":"151","author":"I Sudano","year":"2006","journal-title":"American Heart Journal"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/CRD.0b013e3181b151a3","article-title":"Human immunodeficiency virus and atherosclerosis","volume":"17","author":"P Farrugia","year":"2009","journal-title":"Cardiology in review"},{"key":"ref15","first-page":"115","article-title":"Role of interleukin-18 in the development and pathogenesis of AIDS","volume":"11","author":"A Iannello","year":"2009","journal-title":"AIDS reviews"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1371\/journal.pbio.0040365","article-title":"Human immunodeficiency virus impairs reverse cholesterol transport from macrophages","volume":"4","author":"Z Mujawar","year":"2006","journal-title":"PLoS Biology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/QAI.0b013e3181a9992c","article-title":"Association of C-reactive protein and HIV infection with acute myocardial infarction","volume":"51","author":"V Triant","year":"2009","journal-title":"Journal of acquired immune deficiency syndromes"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"L Kuller","year":"2008","journal-title":"PLoS Medicine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"A Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"ME Charlson","year":"1987","journal-title":"Journal of chronic diseases"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","article-title":"What\u2019s wrong with Bonferroni adjustments","volume":"316","author":"TV Perneger","year":"1998","journal-title":"BMJ British medical journal"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons","volume":"1","author":"KJ Rothman","year":"1990","journal-title":"Epidemiology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/oxfordjournals.aje.a117737","article-title":"Multiple comparisons and related issues in the interpretation of epidemiologic data","volume":"142","author":"DA Savitz","year":"1995","journal-title":"American journal of epidemiology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/oxfordjournals.aje.a009530","article-title":"Invited commentary: Re: \u201cMultiple comparisons and related issues in the interpretation of epidemiologic data\u201d","volume":"147","author":"JR Thompson","year":"1998","journal-title":"American journal of epidemiology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.510240102","article-title":"Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre- and posttreatment with interferon alfa","volume":"24","author":"TV Cacciarelli","year":"1996","journal-title":"Hepatology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/09629359890992","article-title":"Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection","volume":"7","author":"XG Fan","year":"1998","journal-title":"Mediators of inflammation"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"T Wynn","year":"2004","journal-title":"Nature reviews Immunology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/376594a0","article-title":"An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection","volume":"376","author":"TA Wynn","year":"1995","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0030-1255351","article-title":"Chemokines in liver inflammation and fibrosis","volume":"30","author":"H Wasmuth","year":"2010","journal-title":"Seminars in liver disease"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1665-2681(19)31900-3","article-title":"Mechanisms of angiogenesis in chronic inflammatory liver disease","volume":"6","author":"M Chaparro","year":"2007","journal-title":"Annals of hepatology"},{"key":"ref31","first-page":"390","article-title":"Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C. Liver","volume":"16","author":"R Fukuda","year":"1996"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e21381","DOI":"10.1371\/journal.pone.0021381","article-title":"Interleukin-8 Is Activated in Patients with Chronic Liver Diseases and Associated with Hepatic Macrophage Accumulation in Human Liver Fibrosis","volume":"6","author":"HW Zimmermann","year":"2011","journal-title":"PLoS ONE"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI11765","article-title":"PAI-1, fibrosis, and the elusive provisional fibrin matrix","volume":"106","author":"DJ Loskutoff","year":"2000","journal-title":"The Journal of clinical investigation"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10096-010-1149-y","article-title":"Twelve potential fibrosis markers to differentiate mild liver fibrosis from cirrhosis in patients infected with chronic hepatitis C genotype 1","volume":"30","author":"ES Andersen","year":"2011","journal-title":"European journal of clinical microbiology & infectious diseases"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"14562","DOI":"10.1073\/pnas.1210592109","article-title":"Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis","volume":"109","author":"P Farci","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref36","first-page":"3639","article-title":"Monocyte chemotactic protein-1 and soluble adhesion molecules as possible prognostic markers of the efficacy of antiviral treatment in chronic hepatitis C. World Journal of Gastroenterology","volume":"10","author":"A Panasiuk","year":"2004"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/jac\/dkr202","article-title":"Treatment for hepatitis C virus with pegylated interferon-\u03b1 plus ribavirin induces anti-atherogenic effects on cardiovascular risk biomarkers in HIV-infected and -uninfected patients","volume":"66","author":"M Masi\u00e1","year":"2011","journal-title":"Journal of antimicrobial chemotherapy"},{"key":"ref38","first-page":"204","article-title":"A rapid chemokine response of macrophage inflammatory protein (MIP)-1\u03b1, MIP-1\u03b2 and the regulated on activation, normal T expressed and secreted chemokine is associated with a sustained virological response in the treatment of chronic hepatitis C. Clinical microbiology and infection","volume":"17","author":"J Florholmen","year":"2011"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0016-5085(03)01213-7","article-title":"A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease","volume":"125","author":"M M\u03cbhlbauer","year":"2003","journal-title":"Gastroenterology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1042\/CS20060171","article-title":"Immunopathogenesis in hepatitis C virus cirrhosis","volume":"112","author":"U Spengler","year":"2007","journal-title":"Clinical science"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1053\/he.2000.7123","article-title":"Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels","volume":"31","author":"F Calabrese","year":"2000","journal-title":"Hepatology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s10096-011-1215-0","article-title":"Soluble Fas and Fas ligand in HIV\/HCV coinfected patients and impact of HCV therapy","volume":"30","author":"M Guzmn-Fulgencio","year":"2011","journal-title":"European journal of clinical microbiology & infectious diseases"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ccr.2009.08.021","article-title":"A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma","volume":"16","author":"J Haybaeck","year":"2009","journal-title":"Cancer Cell"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0060387","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:20:25Z","timestamp":1589026825000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0060387"}},"subtitle":[],"editor":[{"given":"Ravi","family":"Jhaveri","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,4]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0060387","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,4]]}}}